Twin Health Introduces Precision GLP-1 Stewardship Model, Helping Members Lose More Weight Without Long-Term Dependence

Twin Health, a digital twin care platform for cardiometabolic health, has launched a glucagon-like peptide-1 (GLP-1) Stewardship Model designed to reduce long-term dependence on GLP-1 medications. The program is intended for employers.

No established standard currently exists for how long consumers should remain on GLP-1s or how to safely discontinue them, leaving treatment largely open-ended. Employers face a difficult choice: cover the drugs and absorb ongoing pharmacy costs, or limit access and leave employees without support. Members, meanwhile, often navigate side effects with limited clinical guidance.

Twin's model ties clinical decision-making . . .